{"id":92007,"date":"2026-06-25T13:43:40","date_gmt":"2026-06-25T13:43:40","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/92007\/"},"modified":"2026-06-25T13:43:40","modified_gmt":"2026-06-25T13:43:40","slug":"from-billion-dollar-deals-to-ebola-outbreaks-key-highlights-in-health-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/92007\/","title":{"rendered":"From Billion-Dollar Deals to Ebola Outbreaks: Key Highlights in Health News"},"content":{"rendered":"<p>Health industry headlines feature Antares Therapeutics&#8217; strategic $1.9 billion collaboration with Novartis, targeting hard-to-drug cancer therapies. The agreement underscores a trend of high-stakes partnerships aimed at tackling medical challenges previously considered intractable.<\/p>\n<p>The Democratic Republic of Congo faces mounting difficulties as the Ebola outbreak rapidly spreads. Despite response efforts, the World Health Organization reports the highest first-month case total for any Ebola episode, emphasizing the urgency for international intervention and coordinated health strategies.<\/p>\n<p>Meanwhile, the U.S. continues grappling with rising prescription drug prices. While new drug launch prices have seen a decline in 2025, they remain steep, especially for rare disease treatments. This reflects ongoing discussions about drug affordability and pricing policies in the market.<\/p>\n<p>(With inputs from agencies.)<\/p>\n","protected":false},"excerpt":{"rendered":"Health industry headlines feature Antares Therapeutics&#8217; strategic $1.9 billion collaboration with Novartis, targeting hard-to-drug cancer therapies. The agreement&hellip;\n","protected":false},"author":2,"featured_media":92008,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[45551,46171,46175,14337,1000,44348,46240,41906,206,3505],"class_list":["post-92007","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-advanced-medical-solutions","tag-antares-therapeutics","tag-cancer-drug-deal","tag-congo","tag-drug-prices","tag-ebola-outbreak","tag-h-b-fuller","tag-health-news","tag-novartis","tag-who"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116811045721420527","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=92007"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/92008"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=92007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=92007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=92007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}